Tailor-made antibody therapeutics.
Therapeutic antibodies represent one of the fastest growing areas of the pharmaceutical industry. There are currently 18 monoclonal antibodies in the market that have been approved by the FDA and over 150 in clinical developments. Driven by innovation and technological developments, scientists have gone beyond the traditional antibody molecules. Antibodies have been engineered in a variety of ways to meet the challenges posed by different biological settings. Described in this review is an abridged account of the different ways antibodies have been tailored to make them efficient drug molecules.
Chowdhury
Partha S
PS
Department of Antibody Discovery and Protein Engineering, MedImmune, Inc., One MedImmune Way, Gaithersburg, MD 20878, USA. chowdhuryp@medimmune.com
Wu
Herren
H
D000818:Animals; D000906:Antibodies / Q000235:genetics / Q000302:isolation & purification / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000235:genetics* / Q000302:isolation & purification / Q000627:therapeutic use*; D006801:Humans; D007128:Immunoglobulin Fragments / Q000235:genetics / Q000627:therapeutic use; D051379:Mice; D015202:Protein Engineering / Q000379:methods*; D013678:Technology, Pharmaceutical
D000906:Antibodies; D000911:Antibodies, Monoclonal; D007128:Immunoglobulin Fragments